David F. Nellis

Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and Purification

David F. Nellis, D. Ekström, Dmitri B. Kirpotin et al. · Biotechnology Progress · 2005 · 85 citations

Engineering, Gmp-compliant Process, Affinity Adsorption +18

Preclinical Manufacture of Anti-HER2 Liposome-Inserting, scFv-PEG-Lipid Conjugate. 2. Conjugate Micelle Identity, Purity, Stability, and Potency Analysis

David F. Nellis, Steven L. Giardina, George M. Janini et al. · Biotechnology Progress · 2005 · 81 citations

Proteinlipid Interaction, Protein Purification, Scfv-peg-lipid Conjugate +17

Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague

Jeremy L. Goodin, David F. Nellis, Bradford S. Powell et al. · Protein Expression and Purification · 2007 · 26 citations · Full text

Vaccination, Cross-protection, Protective Efficacy +10

Characterization of Recombinant Human IL-15 Deamidation and Its Practical Elimination through Substitution of Asparagine 77

David F. Nellis, Dennis F. Michiel, Man‐Shiow Jiang et al. · Pharmaceutical Research · 2011 · 17 citations

Cytokine, Autoimmune Disease, Medicine +7

Dynamics differentiate between active and inactive inteins

Melissa Cronin, Michael J. Coolbaugh, David F. Nellis et al. · European Journal of Medicinal Chemistry · 2014 · 13 citations · Full text

Biophysical Modeling, Engineering, Biophysical Aspect +4